Tech news - autumn 2023

1 November 2023
Autumn 2023

A glance at what’s happening in the world of technology.

© Science Photo Library

1. Corticosteroid treatment for uveitic macular oedema shows promise

A clinical trial to evaluate the effectiveness of three different intravitreal treatments for persistent or recurrent uveitic macular oedema found that dexamethasone was significantly better at treating the condition.

Researchers looked at 225 eyes in 194 patients with minimally active or inactive uveitis and persistent or recurrent uveitic macular oedema in one or both eyes. Patients at 33 clinical centres across the US, UK, Australia and India each received one of three therapies: dexamethasone implant, methotrexate or ranibizumab.

At 12 weeks, dexamethasone was found to be significantly better at treating persistent or recurrent macular oedema, giving a 35% reduction in central subfield thickness compared with 22% for ranibizumab and 11% for methotrexate.

Sign in to continue

Forgotten password?
Register

Not already a member of The College?

Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

Nearly a quarter of UK drivers who have been advised to wear glasses while driving admit to not wearing them behind the wheel.

This year's National Eye Health Week will take place from 18 to 24 September 2023, promoting the importance of good eye health and the need for regular sight tests for all.

We are advising people against wearing novelty cosmetic contact lenses this Halloween, unless they have been supplied by an optometrist.